Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line

被引:118
作者
Molloy, CA [1 ]
May, FEB [1 ]
Westley, BR [1 ]
机构
[1] Royal Victoria Infirm, Dept Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
D O I
10.1074/jbc.275.17.12565
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogens can stimulate the proliferation of estrogen-responsive breast cancer cells by increasing their proliferative response to insulin-like growth factors. The mechanism underlying the increased proliferation could involve the induction of components of the insulin-like growth factor signal transduction pathway by estrogen, In this study we have examined the regulation of the expression of insulin receptor substrate-1, a major intracellular substrate of the type I insulin-like growth factor receptor tyrosine kinase, Estradiol increased insulin receptor substrate-1 mRNA and protein levels at concentrations consistent with a mechanism involving the estrogen receptor. Insulin receptor substrate-1 was not induced significantly by the antiestrogens tamoxifen and ICI 182,780, but they inhibited the induction of insulin receptor substrate-1 by estradiol. Analysis of tyrosine-phosphorylated insulin receptor substrate-1 showed that the highest levels were found in cells stimulated by estradiol and insulin-like growth factor-I, whereas low levels were found in the absence of estradiol irrespective of whether type I insulin-like growth factor ligands were present. Insulin receptor substrate-2, -3, and -4 were not induced by estradiol. These results suggest that estrogens and antiestrogens may regulate cell proliferation by controlling insulin receptor substrate-1 expression, thereby amplifying or attenuating signaling through the insulin-like growth factor signal transduction pathway.
引用
收藏
页码:12565 / 12571
页数:7
相关论文
共 50 条
  • [1] INSULIN-LIKE GROWTH FACTOR-1-MEDIATED ASSOCIATION OF P85 PHOSPHATIDYLINOSITOL 3-KINASE WITH PP185 - REQUIREMENT OF SH2 DOMAINS FOR IN-VIVO INTERACTION
    ALTSCHULER, D
    YAMAMOTO, K
    LAPETINA, EG
    [J]. MOLECULAR ENDOCRINOLOGY, 1994, 8 (09) : 1139 - 1146
  • [2] HUMAN SKELETAL-MUSCLE INSULIN-RECEPTOR SUBSTRATE-1 - CHARACTERIZATION OF THE CDNA, GENE, AND CHROMOSOMAL LOCALIZATION
    ARAKI, E
    SUN, XJ
    HAAG, BL
    CHUANG, LM
    ZHANG, Y
    YANGFENG, TL
    WHITE, MF
    KAHN, CR
    [J]. DIABETES, 1993, 42 (07) : 1041 - 1054
  • [3] CHARACTERIZATION AND REGULATION OF THE MOUSE INSULIN-RECEPTOR SUBSTRATE GENE PROMOTER
    ARAKI, E
    HAAG, BL
    MATSUDA, K
    SHICHIRI, M
    KAHN, CR
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (10) : 1367 - 1379
  • [4] The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS - Modulation by insulin growth factor-1 (IGF) and enhanced IGF-1 signaling
    BeitnerJohnson, D
    Blakesley, VA
    ShenOrr, Z
    Jimenez, M
    Stannard, B
    Wang, LM
    Pierce, J
    LeRoith, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) : 9287 - 9290
  • [5] Increased expression of insulin receptor substrate-1 in human pancreatic cancer
    Bergmann, U
    Funatomi, H
    Kornmann, M
    Beger, HG
    Korc, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) : 886 - 890
  • [6] BONNETERRE J, 1990, CANCER RES, V50, P6931
  • [7] BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS
    CAILLEAU, R
    YOUNG, R
    OLIVE, M
    REEVES, WJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) : 661 - 674
  • [8] INSULIN-LIKE GROWTH-FACTOR EXPRESSION IN BREAST-CANCER EPITHELIUM AND STROMA
    CULLEN, KJ
    ALLISON, A
    MARTIRE, I
    ELLIS, M
    SINGER, C
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (01) : 21 - 29
  • [9] DALY RJ, 1994, ONCOGENE, V9, P2723
  • [10] Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol
    Daws, MR
    Westley, BR
    May, FEB
    [J]. ENDOCRINOLOGY, 1996, 137 (04) : 1177 - 1186